Business Description
Central Pharmaceuticals Ltd
ISIN : BD0487CPL007
Compare
Compare
Traded in other countries / regions
CENTRALPHL.Bangladesh IPO Date
2013-08-14Description
Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.38 | |||||
| Debt-to-EBITDA | -4.5 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 0.19 | |||||
| Beneish M-Score | 131.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -56.1 | |||||
| 3-Year FCF Growth Rate | -4 | |||||
| 3-Year Book Growth Rate | -26.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.18 | |||||
| 9-Day RSI | 46.68 | |||||
| 14-Day RSI | 49.91 | |||||
| 6-1 Month Momentum % | -8.06 | |||||
| 12-1 Month Momentum % | -14.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.24 | |||||
| Quick Ratio | 1.14 | |||||
| Days Inventory | 264.26 | |||||
| Days Sales Outstanding | 1122.71 | |||||
| Days Payable | 21.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -190.35 | |||||
| Operating Margin % | -236.12 | |||||
| Net Margin % | -269.82 | |||||
| ROE % | -9.2 | |||||
| ROA % | -5.09 | |||||
| ROIC % | -4.29 | |||||
| ROC (Joel Greenblatt) % | -5.72 | |||||
| ROCE % | -5.91 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 41.14 | |||||
| PB Ratio | 1.86 | |||||
| Price-to-Tangible-Book | 1.85 | |||||
| EV-to-EBIT | -26.35 | |||||
| EV-to-EBITDA | -26.35 | |||||
| EV-to-Revenue | 62.33 | |||||
| EV-to-FCF | -1420.58 | |||||
| Price-to-Projected-FCF | 2.01 | |||||
| Earnings Yield (Greenblatt) % | -3.8 | |||||
| Forward Rate of Return (Yacktman) % | -38.96 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Central Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 25.237 | ||
| EPS (TTM) (BDT) | -0.66 | ||
| Beta | 0 | ||
| Volatility % | 21.84 | ||
| 14-Day RSI | 49.91 | ||
| 14-Day ATR (BDT) | 0.40244 | ||
| 20-Day SMA (BDT) | 11.035 | ||
| 12-1 Month Momentum % | -14.29 | ||
| 52-Week Range (BDT) | 9.9 - 14.9 | ||
| Shares Outstanding (Mil) | 119.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Central Pharmaceuticals Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Central Pharmaceuticals Ltd Stock Events
| Event | Date | Price(BDT) | ||
|---|---|---|---|---|
| No Event Data | ||||
Central Pharmaceuticals Ltd Frequently Asked Questions
What is Central Pharmaceuticals Ltd(DHA:CENTRALPHL)'s stock price today?
The current price of DHA:CENTRALPHL is BDT10.90. The 52 week high of DHA:CENTRALPHL is BDT14.90 and 52 week low is BDT9.90.
When is next earnings date of Central Pharmaceuticals Ltd(DHA:CENTRALPHL)?
The next earnings date of Central Pharmaceuticals Ltd(DHA:CENTRALPHL) is .
Does Central Pharmaceuticals Ltd(DHA:CENTRALPHL) pay dividends? If so, how much?
Central Pharmaceuticals Ltd(DHA:CENTRALPHL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers